arrow
A

Angela Buonadonna

centro di riferimento oncologico di aviano (cro), irccs
H指数:45
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Validity of Imatinib Therapeutic Drug Monitoring in a Real-World Italian Cohort of Gastrointestinal Stromal Tumors and the Role of Patients’ Sex

伊马替尼治疗药物监测在真实世界意大利胃肠间质瘤队列中的临床有效性和患者性别的作用

2026-08-110
OA
Triplet chemotherapy combined with anti Epidermal Growth Factor Receptor treatment in RAS wild-type colorectal cancer: a network metanalysis

三联化疗联合抗表皮生长因子受体治疗RAS野生型结直肠癌:一项网络Meta分析

2026-03-010
PRE
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase 2 study from the Italian Sarcoma Group

Trabectedin-olaparib联合治疗或trabectedin单药治疗在经蒽环类为基础治疗失败的晚期软组织肉瘤中的应用(TOMAS2):一项来自意大利肉瘤组的随机Ⅱ期研究

2025-12-050
PRE
Imatinib and norimatinib therapeutic monitoring using dried blood spots: Analytical and clinical validation, and performance comparison of volumetric collection devices

使用干血斑进行伊马替尼和诺利替尼治疗药物监测:分析验证与临床验证,以及体积收集装置的性能比较

2025-04-010
PRE
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial

重新定义接受新辅助化疗的高风险软组织肉瘤的放射学反应:ISG-STS 1001随机临床试验的最终结果

2025-03-010
OAAI
Negative hyperselection and mechanisms of acquired resistance to first-line chemotherapy plus anti-EGFR in pMMR RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts): A translational analysis of the TRIPLETE trial
2024-06-010
PRE
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group
2024-05-012
OAAI
TOMAS2: A randomized phase II study from the Italian Sarcoma Group (ISG) of trabectedin plus olaparib (T plus O) or trabectedin (T) in advanced, metastatic, or unresectable soft tissue sarcomas (STS) after failure of standard treatments
2023-10-014
PRE
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis
2022-12-083
OAAI
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO
2022-09-015
PRE
Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studies
2022-07-019
PRE
Modified FOLFOXIRI plus panitumumab (mFOLFOXIRI/PAN) versus mFOLFOX6/PAN as initial treatment of unresectable RAS/BRAF wild-type metastatic colorectal cancer (mCRC) patients: Results of the phase III randomized TRIPLETE study by GONO
2022-06-010
OA
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

胃肠道间质瘤: esmo-euracan-GENTURIS诊断,治疗和随访的临床实践指南

2022-01-01269
OAAI